CVR: 36445564
Bionor Pharma ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014 and dissolved in 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees. In 2016, the company reported a gross profit of DKK 7,876,382 and a net result of DKK 724,593. Equity amounted to DKK 4,401,846.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorScreen owners and management against the Danish FSA's official PEP lists
As of December 6, 2017, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Bionor Pharma ApS.
As of December 6, 2017, Regina Møller Andersen has stepped down as liquidator of Bionor Pharma ApS.
On December 6, 2017, Bionor Pharma ApS exited liquidation.
Bionor Pharma ApS was dissolved on December 6, 2017.
Bionor Pharma ApS has published its annual report for 2016. Gross profit came to DKK 7,876,382, and the net result was DKK 724,593.
As of November 1, 2016, Gunnar Arne Flåten has left the board of directors of Bionor Pharma ApS.
As of November 1, 2016, Unni Hjelmaas has left the board of directors of Bionor Pharma ApS.
As of November 1, 2016, Regina Møller Andersen is registered as liquidator of Bionor Pharma ApS.
As of November 1, 2016, Per-Sveno Thoresen has stepped down as chairman of Bionor Pharma ApS.
As of November 1, 2016, Unni Hjelmaas has stepped down as adm. dir. of Bionor Pharma ApS.
On November 1, 2016, Bionor Pharma ApS entered liquidation.
Bionor Pharma ApS has published its interim report for the period November 15, 2014 – December 31, 2015.
As of June 13, 2016, Per-Sveno Thoresen is registered as chairman of Bionor Pharma ApS.
As of June 12, 2016, Per-Sveno Thoresen has left the board of directors of Bionor Pharma ApS.
As of May 20, 2016, Per-Sveno Thoresen has joined the board of directors of Bionor Pharma ApS.
As of May 20, 2016, Unni Hjelmaas has joined the board of directors of Bionor Pharma ApS.
As of May 20, 2016, Søren Vitfell Keller has left the board of directors of Bionor Pharma ApS.
As of May 20, 2016, David Horn Solomon has left the board of directors of Bionor Pharma ApS.
As of May 20, 2016, Unni Hjelmaas is registered as adm. dir. of Bionor Pharma ApS.
As of May 20, 2016, David Horn Solomon has stepped down as director of Bionor Pharma ApS.
As of May 12, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of Bionor Pharma ApS.
As of May 12, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Bionor Pharma ApS.
As of March 12, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Bionor Pharma ApS.
As of March 12, 2015, Søren Vitfell Keller has joined the board of directors of Bionor Pharma ApS.
As of March 12, 2015, David Horn Solomon has joined the board of directors of Bionor Pharma ApS.
As of March 12, 2015, Gunnar Arne Flåten has joined the board of directors of Bionor Pharma ApS.
As of March 12, 2015, Peter Andreas Stakemann has left the board of directors of Bionor Pharma ApS.
As of March 12, 2015, Ulf Lund has left the board of directors of Bionor Pharma ApS.
As of March 12, 2015, David Horn Solomon is registered as director of Bionor Pharma ApS.
As of March 12, 2015, Peter Andreas Stakemann has stepped down as direktion of Bionor Pharma ApS.
As of March 12, 2015, Thomas Jeffrey Malherbes Gullacksen has stepped down as chairman of Bionor Pharma ApS.
As of November 15, 2014, Peter Andreas Stakemann has joined the board of directors of Bionor Pharma ApS.
As of November 15, 2014, Ulf Lund has joined the board of directors of Bionor Pharma ApS.
As of November 15, 2014, Peter Andreas Stakemann is registered as direktion of Bionor Pharma ApS.
As of November 15, 2014, Thomas Jeffrey Malherbes Gullacksen is registered as chairman of Bionor Pharma ApS.
Bionor Pharma ApS was founded on November 15, 2014.